作者单位：
Chromatin and Disease Group, Cancer Epigenetics and Biology Programme (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avda. Gran Via 199-203, 08908, L’Hospitalet de Llobregat, Barcelona, Spain
[1]
Hematology Division, Brigham and Women’sHospital, Harvard Medical School, One Blackfan Circle, Brookline, MA, 02115, USA
[2]
CR-UK Institute for Cancer Studies, University of Birmingham, Vincent Drive, Birmingham, B15 2TT, UK
[3]
Hematology Division, Brigham and Women’s Hospital, Harvard Medical School, One Blackfan Circle, Brookline, MA, 02115, USA
[4]
Cancer Epigenetics Laboratory, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), HUCA, Universidad de Oviedo, C/Dr. Emilio Rodríguez Vigil, s/n, 33006, Oviedo, Spain
[5]
Department of Experimental and Health Sciences, Barcelona Biomedical Research Park, Universitat Pompeu Fabra (UPF), c/Dr. Aiguader, 88, 08003, Barcelona, Spain
[6]
Broad Institute, 7 Cambridge Center, Cambridge, MA, 02142, USA
[7]
Cellular Differentiation Group, Cancer Epigenetics and Biology Programme (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Avda. Gran Via 199-203, 08908, L’Hospitalet de Llobregat, Barcelona, Spain
[8]
发布时间
2013-11-20
换一批
换一批
